In Vivo Administratration of Interleukin-2
- 1 January 1985
- book chapter
- Published by Springer Nature
- Vol. 10, 263-282
- https://doi.org/10.1007/978-1-4684-4838-2_11
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Interleukin 1 is more than an interleukinImmunology Today, 1982
- Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.The Journal of Experimental Medicine, 1982
- Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.The Journal of Experimental Medicine, 1982
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2.The Journal of Experimental Medicine, 1981
- Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans.Journal of Clinical Investigation, 1981
- Recovery of the capacity for cytotoxic T cell generation in cyclophosphamide-treated mice by the addition of Lyt-1+2− helper cellsInternational Journal of Immunopharmacology, 1980
- T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu miceNature, 1980
- Long term culture of tumour-specific cytotoxic T cellsNature, 1977
- MODELS FOR SYNGENEIC ADOPTIVE CHEMOIMMUNOTHERAPY OF MURINE LEUKEMIAS*Annals of the New York Academy of Sciences, 1976